Inhibitor Masking Device & Sodium Channel, Voltage Gated, Type IX Alpha Subunit (SCN9) Gene Expression

Stopped early · Not applicable

Conditions studied: Tinnitus

In brief

To evaluate the effectiveness of the Inhibitor™ Tinnitus Masking Device. To determine if there is a higher incident of expression of the sodium channel, voltage gated, type IX alpha subunit (SCN9) gene in those subjects with disturbing tinnitus than subjects that are not disturbed by tinnitus.

Key facts

Study ID

NCT01412918

Run by

Medical College of Wisconsin

People needed

21

Starts

2011-09-01

Expected to finish

2014-01-01

Last updated by the study team

2016-02-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• over 18 years,
• has tinnitus

You may not qualify if…

• Pacemaker,
• pregnancy,
• metal implants in head or neck,
• thrombosis, migraines/headaches,
• metal bonded retainer, surgeries within the last 6 months which patient is still recovering from,
• any medical reason your physician would advise against the use of this device,
• under 18 years

Where it is running

• Froedtert & The Medical College of Wisconsin — Milwaukee, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.